Background: The molar pregnancy is complicated with hypertension before 20 weeks, divided into complete mole and partial mole, and in diploid and triploid hydatidiform mola depending on the fetal chromosomes.

Objective: To determine clinical and laboratory characteristics of patients with hydatidiform mole with and without hypertension, and choriocarcinoma, correlate serum chorionic gonadotropin (hCG) and hypertension.

Material And Methods: We reviewed 55 cases with histopathologically proven mole, separately analyzed clinical, laboratory and hCG.

Results: The prevalence of mole with hypertension was 1:7; with the choriocarcinoma is 1:11. The age and sexual initiation of mole with hypertension was higher (p = .004 and .002 respectively), liver transaminase AST (p =. 004) and lactate dehydrogenase are higher in the group with hypertension (p =. 000). Positive correlation was obtained r = .246 p =. 044 statistically significant between mean arterial pressure and hCG. We reviewed 31 cases of 28 national and international articles, in patients with diploid hydatidiform the product is allowed to live normal and high blood pressure is showing mild preeclampsia, while partial moles are triploid, malformed products, incompatible with life and with hypertension severe like severe pre-eclampsia.

Conclusions: The molar pregnancy is partially diagnosed with hypertension in our environment, is not properly analyzed and that most of the products of curettage were not performed genetic testing. The hCG probably participate in the hypertensive disorders of pregnancy.

Download full-text PDF

Source

Publication Analysis

Top Keywords

mole hypertension
12
characteristics patients
8
molar pregnancy
8
clinical laboratory
8
hypertension choriocarcinoma
8
reviewed cases
8
hypertension
7
mole
6
[clinic characteristics
4
patients trophoblastic
4

Similar Publications

Background: There are no clinical or laboratory markers that can diagnose acute mesenteric ischemia (AMI) accurately. This study aimed to find differences in clinical and laboratory markers between arterial occlusive AMI and other acute abdominal diseases where AMI was initially suspected.

Methods: This was a post hoc study of an international prospective multicenter study where data on patients with suspected AMI were collected.

View Article and Find Full Text PDF
Article Synopsis
  • - Of the 5 randomized controlled trials (RCTs) analyzed, 20% of participants had chronic thromboembolic pulmonary hypertension (CTEPH), but none specifically studied the impacts of exercise training in these patients.
  • - The study suggests that exercise training can enhance exercise capacity in pulmonary hypertension (PH) patients, specifically indicated by improvements in 6-minute walk distance.
  • - It also highlights that exercise training appears to be safe for patients with CTEPH and pulmonary arterial hypertension (PAH), challenging the common belief that exercise is risky for these individuals.
View Article and Find Full Text PDF

Gestational trophoblastic disease is a group of pregnancy-related trophoblastic tumours. Gestational trophoblastic neoplasia refers to its invasive and malignant forms: invasive mole, choriocarcinoma, placental site trophoblastic tumour and epithelioid trophoblastic tumour. Patients exhibit elevated beta human chorionic gonadotropin (β hCG) levels, sometimes exceeding 100 000 mIU/mL.

View Article and Find Full Text PDF

Bohring-Opitz syndrome (BOS) is a rare disease with a characteristic facial appearance and limb position. This report describes a case of BOS complicated by persistent pulmonary hypertension of the newborn (PPHN) and formation of abnormal alveoli that was confirmed by autopsy. A female neonate was born by cesarean section at 37 weeks and 2 days of gestation and found to have a nevus flammeus, exophthalmos, abnormal palate, retraction of the mandible, and a posture characteristic of BOS.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!